醫療器械是否回暖 貝康醫療(2170.HK)上半年銷售業績逆勢爆發 Suzhou Basecare Medical Corporation Limited Jul 15, 2024 08:51 HKT/SGT Read More
医疗器械是否回暖 贝康医疗(2170.HK)上半年销售业绩逆势爆发 Suzhou Basecare Medical Corporation Limited Jul 15, 2024 07:42 HKT/SGT Read More
CEO Periodic Update for 2024 and Review on the Market of the Growing FemTech Industry Femto Technologies Inc Jul 15, 2024 04:00 HKT/SGT Read More
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Israel Eisai Jul 12, 2024 11:56 HKT/SGT Read More
LEQEMBI (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Hong Kong Eisai Jul 11, 2024 09:00 HKT/SGT Read More
CEO Periodic Update for 2024 and Review on the Market of the Growing FemTech industry Femto Technologies Inc Jul 10, 2024 21:06 HKT/SGT Read More
AIVF Set to Transform the IVF Process With AI Technology in the Australian Market AIVF Jul 09, 2024 23:10 HKT/SGT Read More
Eisai: "LEQEMBI" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in China Eisai Jun 28, 2024 14:57 HKT/SGT Read More
Perfect Medical Announces Annual Results for FY2023/24 Perfect Medical Health Management Limited Jun 28, 2024 14:45 HKT/SGT Read More
CGFNS International Announces First Global Credential for Rehab Nurses CGFNS International Jun 28, 2024 06:00 HKT/SGT Read More
Mobile-health Network Solutions and Ryde Group Ltd Sign Partnership Agreement Mobile-health Network Solutions Pte Ltd Jun 27, 2024 21:50 HKT/SGT Read More
ONERHT Foundation's 7th GAIL Forum highlights urgent need to incorporate sustainability into everyday practices and company culture ONERHT Foundation Jun 26, 2024 18:04 JST Read More
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China China Medical System Holdings Ltd. Jun 25, 2024 21:46 JST Read More
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China China Medical System Holdings Ltd. Jun 25, 2024 20:00 HKT/SGT Read More
[Media Alert] Are You 'Man' Enough to Embrace Your Inner Health? LAC Global Jun 25, 2024 16:00 HKT/SGT Read More
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics Inc. Jun 21, 2024 18:30 HKT/SGT Read More